Ailurus Bio logo

Ailurus Bio

Programming biology to automate and accelerate science.

17 employees · est. 2022 · London, United Kingdom

VS
SynHelix logo

SynHelix

Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply needs.

11-50 employees · est. 2019 · Evry, France

SynHelix is the older company (2022 vs 2019).

Side-by-Side Comparison

Ailurus Bio SynHelix
Founded
2022 2019 older
Headquarters
London, United Kingdom Evry, France
Employees
17 11-50
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology
Funding Stage
Undisclosed Not tracked yet
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
1 Not tracked yet
Services
PandaPure Protein Systems, Ailurus vec Expression Libraries, Construct Design and Building, Metabolic Engineering Not tracked yet
Target Customers
Researchers, Biodevelopers, Synthetic Biologists, Life Science Companies, Biotechnology Firms, R&D Laboratories Not tracked yet
Taxonomy
Synthetic Biology, Bioengineering, Biological Programming, Molecular Biology, AI Integration, Lab Automation, High-throughput Screening, Biocomputing, Cloud Biocomputation, Genetic Instruction Development, Biological Software, Strain Optimization, Protein Purification, Self-Driving Labs, Biocomputer Architecture Synthetic Biology, DNA Constructs, Molecular Biology, Gene Synthesis, Gene Therapy, Biotherapeutics, Protein Engineering, Recombinant Proteins, Biochemistry, Enzymology, Computational Biology, Cell Therapy, Nanotechnology
Website
ailurus.bio synhelix.com
Ailurus Bio logo

About Ailurus Bio

Ailurus Bio, founded in 2022 and headquartered in the United Kingdom, is a trailblazer in the Biopharma, Biotechnology, and Life Sciences sectors. The company's mission, encapsulated by its slogan "Programming biology to automate and accelerate science," revolves around transforming lab-grown cells...

SynHelix logo

About SynHelix

SynHelix is a biotech startup based in France, founded in 2019, that has identified a significant market opportunity in the rapidly growing demand for synthetic DNA in fields such as synthetic biology, gene therapy, and diagnostics. The company aims to address the current supply bottleneck faced by...

We will tell you when either one moves

BounceWatch watches Ailurus Bio and SynHelix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ailurus Bio and SynHelix — by email.

Frequently Asked Questions

Ailurus Bio — Programming biology to automate and accelerate science.. SynHelix — Demand for synthetic DNA is growing rapidly in biotech industry, and SynHelix aims to meet supply needs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ailurus Bio and SynHelix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ailurus Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ailurus Bio on 15 Jun 2026, and SynHelix on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy